EP1005831A3 — A method for measurement of a penile diameter
Assigned to Eisai Co Ltd · Expires 2001-05-30 · 25y expired
What this patent protects
The object of the invention is to establish a measurement method wherein the increase in penile diameter can be monitored for long periods, without the damage to tissues by insertion of a measurement needle as the disadvantage of conventional methods measuring the internal pressu…
USPTO Abstract
The object of the invention is to establish a measurement method wherein the increase in penile diameter can be monitored for long periods, without the damage to tissues by insertion of a measurement needle as the disadvantage of conventional methods measuring the internal pressure of the corpus cavernosum. According to the invention, a pair of piezoelectric crystals are fitted on the opposite surfaces of the adventitia of the penile erectile chamber using an adhesive agent and connected via an ultrasonic dimension system to a polygraph system, and the increase in the penile diameter upon erectile response is continuously recorded on a chart in a recorder.
Drugs covered by this patent
- Androgel (TESTOSTERONE) · Besins Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.